Delivery Order SPE2DB20D1004-SPE2DB22FF1K4
Award Date
1/20/22
Potential Completion Date
1/21/22
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,875.86 firm fixed-price delivery order is for the supply of Glatopa 40 mg/mL syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the supply of Glatopa 40 mg/ml syringes, a specialty medication, with a ceiling value of $8,388.16. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of November 14, 2023. This contract award is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,085.54 firm fixed-price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGE, a specialty medication. The award is a part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, valued at $1,688.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of April 14, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of GLATOPA 40 MG/ML SYRINGE medication to support military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, with a ceiling value of $6,173.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 4, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,158.51 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGE, a specialty medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,039.05 Firm Fixed Price delivery order is for the supply of 4,560,716,059 units of Glatiramer 40 mg/mL syringes. The contract has an ultimate completion date of April 26, 2023. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,644.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Glatopa 20 mg/mL syringes, a medication used to treat multiple sclerosis. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...